Hints and tips:
...While not seen in Germany before, Braas’s tactic has some similarities to that deployed by French drugmaker Aventis in 2004, in an attempt to avoid being acquired by Sanofi in a $60bn deal....
...Mr Soriot, 53, a Frenchman who trained as a veterinary surgeon before obtaining an MBA, worked for much of his career in Asia for Roussel Uclaf, Hoechst and Aventis, which became part of Sanofi in 2004....
...The former ABB, Aventis and Hoechst boss was selected for his international experience and management skills....
...Novartis, GlaxoSmithKline and Sanofi-Aventis, are among other large pharmaceutical groups which have expanded in generics in recent years....
...Swiss peer Roche lost 0.5 per cent to SFr175.10 and Sanofi-Aventis in France weakened 0.4 per cent to €56.33. Healthcare equipment and services firms gained....
...These bidders face competition from pharmaceutical buyers, including Teva of Israel and Sanofi-Aventis of France. Ratiopharm, founded in 1973, was Germany’s first generic drug maker....
...Israeli generic group Teva, French drugmaker Sanofi-Aventis, US company Mylan and a series of financial investors are believed to be among the possible suitors....
...The Germans have yet to digest the way the French blocked Siemens’ efforts to expand in France and absorbed Hoechst after it merged with Rhône-Poulenc to create Aventis....
...6.3 per cent to €234.49, BMW lost 2.1 per cent to €31.67 and Daimler was off 3.2 per cent to €32.73, while Porsche dropped 0.3 per cent to close at €46.01 Pharmaceuticals produced mixed results, with Sanofi-Aventis...
...Innovative pharmaceutical companies such as GlaxoSmithKline in the UK, Sanofi-Aventis in France and Pfizer in the US are expanding their generic drugs activities, but concentrating on faster growing emerging...
...In the wake of Pfizer’s $68bn takeover of Wyeth last week, Sanofi-Aventis has held talks with bankers about possible deals....
...Individuals close to the discussions said Pfizer, Sanofi-Aventis and Novartis, three of the world’s largest drug developers, had expressed interest, as well as GlaxoSmithKline, reflecting the growing desire...
...Daiichi Sankyo of Japan last year bought the Indian generics group Ranbaxy, and Sanofi-Aventis of France recently completed the purchase of Zentiva, based in the Czech Republic....
...Novartis, GlaxoSmithKline, Sanofi-Aventis and Daiichi Sankyo of Japan have also diversified into the field....
...There again, now that the Dutch group has flagged its interest in a takeover, Sanofi-Aventis and its rivals may come back with counter-offers....
...Instead, stories of failed deals dominated after reports suggested Sanofi-Aventis, the French drugmaker, had ended talks with Bristol-Myers Squibb. Sanofi shares gained 0.4 per cent to €67.80....
...ne-Poulenc to create Aventis, and the group?s subsequent absorption by France?s Sanofi, killed a national champion....
...In the last three years, new investors have included Robert Bosch, a German energy and electronics company, Sanofi-Aventis, a French drugs maker, and Baumit, an Austrian building materials producer....
...Shortlisted companies were Sanofi-Aventis, Faurecia and Tecnip....
...Sanofi-Aventis, the French drugmaker, raised its 2005 earnings growth forecast following a 4.8 per cent rise in fourth-quarter sales....
...It follows a bout of economic nationalism in France, where the government last year engineered the takeover of Aventis, the pharmaceuticals company, by rival Sanofi, and the bailout of engineering group...
...labo's acquisition of Franco-German Aventis this year.? Thomas H?ne, spokesman for the BDI industry federation, said: ?...
...Hard on the heels of the French government-backed takeover of the Franco-German Aventis by Sanofi-Synthélabo, here was another dirigiste betrayal of European ideals to promote Gallic supremacy....
International Edition